hydralazine and tak 044

hydralazine has been researched along with tak 044 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kano, H; Kohno, M; Minami, M; Tatsumi, Y; Ueda, M; Yasunari, K; Yokokawa, K; Yoshikawa, J	1

Other Studies

1 other study(ies) available for hydralazine and tak 044

Article	Year
Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:9 Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Endothelin Receptor Antagonists; Hydralazine; Hypertension, Malignant; Kidney; Male; Myocardium; Organ Size; Peptides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Reference Values; Sodium Chloride	1997

Article

Year

Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.

Metabolism: clinical and experimental, 1997, Volume: 46, Issue:9

Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Endothelin Receptor Antagonists; Hydralazine; Hypertension, Malignant; Kidney; Male; Myocardium; Organ Size; Peptides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Reference Values; Sodium Chloride

1997